The launch of GLP-1 weight-loss drugs in India is gaining popularity. Harvard researchers share a comprehensive guidance for ...

According to a new feature by the Washington Post, approximately 16 million American adults are on GLP-1 drugs such as ...

A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings ...

New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.

People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...

GLP-1 anti-obesity medications are linked with improvements in testosterone levels and health outcomes for men with obesity or type 2 diabetes, researchers reported in San Francisco at ENDO 2025, the ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes management.

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

Massachusetts health insurers are effectively telling the drug companies that they may seek a rapidly growing customer base or charge unjustifiably high prices, but they can’t have both.

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...